Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation. [PDF]
Sci Rep, 2020 This study was entirely funded by Project FIS: PI-17/00547 (Instituto Carlos III, Ministerio de Economia y Competitividad, Spain), which means that it was also partially supported by European Regional Development Funds (ERDF).Aflibercept (AFL) is an Fc ...
Hermosilla J +6 more
europepmc +11 more sources
Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept [PDF]
Clinical Ophthalmology, 2019 Ahmad M Mansour,1,2 Khalil El Jawhari,3 J Fernando Arevalo4 1Department of Ophthalmology, American University of Beirut, Beirut, Lebanon; 2Department of Ophthalmology, Rafik Hariri University Hospital, Beirut, Lebanon; 3Medical School, Medical ...
Mansour AM, El Jawhari K, Arevalo JF
doaj +5 more sources
Taiwan Journal of Ophthalmology, 2020 PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD).
Sumit Randhir Singh +7 more
doaj +3 more sources
Comparison of antiangiogenic agents (ranibizumab, aflibercept, bevacizumab and ziv-aflibercept) in the therapeutic response to the exudative form of age-related macular degeneration according to the treat-and-extend protocol- true head-to-head study [PDF]
International Journal of Retina and VitreousPurpose To evaluate the structural and functional changes in eyes with neovascular age related macular degeneration (nAMD) in a real-world setting, using Treat and Extend protocol (T&E), comparing four antiangiogenic agents.
Tereza Kanadani +4 more
doaj +4 more sources
Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy [PDF]
Indian Journal of Ophthalmology, 2019 Purpose: To report the visual and anatomical outcomes of intravitreal ziv-aflibercept (IVZ) and bevacizumab (BVZ) monotherapy in treatment-naive polypoidal choroidal vasculopathy (PCV).
Sumit Randhir Singh +3 more
doaj +3 more sources
Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies [PDF]
Journal of Pharmaceutical and Biomedical Analysis, 2021 The study was entirely funded by Project FIS: PI-17/00547(Instituto Carlos III, Ministerio de Economia y Competitividad, Spain), which means that it was also partially supported by European Regional Development Funds (ERDF).A range of biopharmaceutical ...
Jesus +2 more
exaly +5 more sources
One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion [PDF]
American Journal of Ophthalmology Case Reports, 2017 Purpose: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO).
Ahmad M Mansour +2 more
exaly +4 more sources
CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION AFTER INTRAVITREAL ZIV-AFLIBERCEPT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. [PDF]
Retina, 2017 Purpose: To evaluate the 6-month safety and efficacy of ziv-aflibercept intravitreal injections for treating exudative age-related macular degeneration.
de Oliveira Dias JR +8 more
europepmc +5 more sources
FOLFOX plus ziv‐aflibercept or placebo in first‐line metastatic esophagogastric adenocarcinoma: A double‐blind, randomized, multicenter phase 2 trial [PDF]
Cancer, 2019 James M Cleary +2 more
exaly +4 more sources
Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study. [PDF]
PLoS ONE, 2019 AIM:To evaluate the safety of 1.25mg and 2mg intravitreal ziv-aflibercept (IVZ) in Ghanaian eyes with choroido-retinal vascular diseases. DESIGN:Prospective, randomised, double blind, interventional study.
Imoro Zeba Braimah +5 more
doaj +4 more sources